Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Originally identified as reproductive hormones, estrogens are now generally thought to play important roles in bone, the cardiovascular system and in the central nervous system. This expanded view of estrogen action reflects the findings of a large number of clinical studies and a huge body of empirical observational data gathered on the effects of exogenous estrogen administration on the health of menopausal women. Parallel studies reporting the distribution of estrogen receptors and others describing specific estrogenic responses in functionally related tissues have led to an appreciation of the sphere of influence of this hormone. Not surprisingly, therefore, although estrogen-containing medicines were first introduced in the late 1940s as treatments for the climacteric symptoms associated with menopause, there has since been a realization that these hormones may have additional beneficial effects in nonreproductive targets. So strong were the data in support of these adjunct activities of estrogens that long-term estrogen therapy (ET) or hormone therapy (HT) 1 HT describes regimens in which a progestin is administered in a continuous or sequential manner with an estrogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Estrogen receptor (ER) β, a modulator of ERα in the uterus
Weihua, Z., Saji, S., Mäkinen, S., Cheng, G., Jensen, E. V., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5936 · Cited by 507
Harris, H. A., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2002) · Endocrinology · doi:10.1210/en.2002-220403 · Cited by 357
Cited by
Structure–function relationship of estrogen receptor α and β: Impact on human health
Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 499
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
Shang, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1879 · Cited by 246
Osteoporosis in patients with chronic kidney diseases: A systemic review
Hsu, C.-Y., Chen, L.-R., & Chen, K.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186846 · Cited by 162
“It manifests estrogenic activity in bone, and in cardiovascular systems while opposing estrogen action in the uterus and breast [157], thus displaying less risk of invasive breast cancers compared with estrogens.”
BackgroundMedical Treatment for Osteoporosis: From Molecular to Clinical Opinions
Chen, L.-R., Ko, N.-Y., & Chen, K.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092213 · Cited by 116
Metadata
- Authors
- McDonnell, D. P.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-10-01
- Volume
- 144
- Issue
- 10
- Pages
- 4237-4240
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2027190720
- Cited by
- 42
- References
- 4
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics. https://app.cochat.ai/papers/10.1210/en.2003-0900
- The paper
- McDonnell, D. P. (2003). Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics. Endocrinology. https://doi.org/10.1210/en.2003-0900
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.